Currently, several projects at the park are in stages such as evaluating master plans and adjusting detailed construction plans at a 1/500 scale. The management board is coordinating with relevant departments and agencies to carry out investment and construction procedures while adjusting investment registration certificates to ensure the timely implementation of projects.
On January 6, the construction of a plasma-derived biopharmaceutical production plant officially started in the SHTP.
The plant is scheduled to become operational in February 2026, with a production capacity of 6,000 litres of plasma per year, meeting the treatment demand of 250 million people.
It is also expected to help ensure a strategic medical reserve for the nation, enable prompt responses to epidemics and natural disasters, and reduce reliance on imported pharmaceuticals.
The SHTP has so far attracted investments from more than 10 leading global hi-tech corporations, including Intel, Jabil, and Rockwell of the US, Nidec, Nipro, and NTT of Japan, Samsung of the Republic of Korea (RoK), Sanofi of France, and TTI of Germany. It is now home to 160 valid investment projects worth 12.3 billion USD.
To draw more investment inflows into the park, the municipal authorities are further investing in developing a science and technology park with a total area of nearly 200 ha in Thu Duc city, about 2 km from the SHTP. This is hoped to be a new factor for the development of HCM City, especially in attracting investment in hi-tech industries, with a ripple effect in the region, and meeting the requirements for the southern metropolis’s green, sustainable economic development./. VNA